Andrew Cunningham
Hoofd Techniek/Wetenschap/O&O bij CALCIMEDICA, INC.
Oorsprong van het eerstegraads netwerk van Andrew Cunningham
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
| Subsidiary | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 7 | |
| Public Company | Biotechnology | 2 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andrew Cunningham via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | General Counsel | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Hambrecht & Quist Group, Inc. operates as a holding investment bank and provides securities brokerage services. The company is headquartered in San Francisco, CA. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | General Counsel | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | General Counsel | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO Director/Board Member Founder Chief Executive Officer President | |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | General Counsel | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree | |
| Gustavus Adolphus College | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
| Oregon State University | College/University | Graduate Degree | |
| Pepperdine University | College/University | Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree Doctorate Degree | |
| NAVIOS MARITIME HOLDINGS INC. | Marine Shipping | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Texas University of Health Center at San Antonio | College/University | Doctorate Degree | |
Caxton Health Holdings LLC
 Caxton Health Holdings LLC Financial ConglomeratesFinance Caxton Health Holdings LLC operates as an investment firm. It focus on healthcare sectors, such as healthcare technologies, biopharmaceuticals, drug discovery technology and healthcare information technology. The company is headquartered in New York, NY. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| UBS Warburg, Inc. | Corporate Officer/Principal | ||
| THERACLION | Medical Specialties | Director/Board Member | |
| The University of Cincinnati College of Medicine | College/University | Doctorate Degree | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Clearity Foundation
 The Clearity Foundation Investment Trusts/Mutual FundsMiscellaneous The Clearity Foundation is a non-profit organization that functions as a foundation or endowment. The private company is based in San Diego, CA. The company was founded by Laura K. Shawver. | Investment Trusts/Mutual Funds | Chief Operating Officer | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Valence Life Sciences LLC
 Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | General Counsel | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Colorado Kidney Care P.C.
 Colorado Kidney Care P.C. Medical/Nursing ServicesHealth Services Colorado Kidney Care P.C. provides healthcare services. The firm offers nephrology, nutrition, access, transplant, dialysis, lupus nephritis, kidney smartSM, research, options education and care coordination services. The company was founded in 1991 and is headquartered in Denver, CO. | Medical/Nursing Services | Corporate Officer/Principal | |
Valence Investments SPV IV LLC
 Valence Investments SPV IV LLC BiotechnologyHealth Technology Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Optogenetics Research, Inc.
 Novartis Optogenetics Research, Inc. BiotechnologyHealth Technology Vedere Bio, Inc. develops cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss. The company was founded in June 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Retrophin Pharmaceutical, Inc.
 Retrophin Pharmaceutical, Inc. BiotechnologyHealth Technology Part of Travere Therapeutics, Inc., Travere Therapeutics Pharmaceutical, Inc. is an American company that engages in the development of drugs for the treatment of debilitating and often life-threatening diseases. The company is based in DE. | Biotechnology | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Canada | 4 |
| Zwitserland | 2 |
| Kaaimaneilanden | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 139 |
| Corporate Officer/Principal | 106 |
| Director of Finance/CFO | 68 |
| Independent Dir/Board Member | 44 |
| Undergraduate Degree | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Martin Edwards | 38 |
| Fred Middleton | 30 |
| Allan Shaw | 23 |
| Eric Bjerkholt | 21 |
| Eric Roberts | 18 |
| Rachel Leheny | 17 |
| John Dunn | 15 |
| Robert Wilson | 14 |
| Manmeet Singh Soni | 13 |
| Richard A. Moscicki | 13 |
| Peter DiLaura | 13 |
| Michael Dunn | 12 |
| James E. Bass | 11 |
| Frédéric Guerard | 10 |
- Beurs
- Insiders
- Andrew Cunningham
- Bedrijfsconnecties
